Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids
NACompletedINTERVENTIONAL
Enrollment
56
Participants
Timeline
Start Date
April 30, 2007
Primary Completion Date
October 31, 2008
Study Completion Date
June 30, 2011
Conditions
Liver Cancer
Interventions
DRUG
LIVACT
LIVACT contains 13.0 g of free amino acids
Trial Locations (1)
783-8505
Kochi Medical School, Nankoku
All Listed Sponsors
lead
Kochi University
OTHER
NCT01434524 - Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids | Biotech Hunter | Biotech Hunter